MYM Nutraceuticals Inc.

Recent News

  • MYM Provides Timeline for Special Meeting of Shareholders and Announces Exchange of Special Shares

    Vancouver, British Columbia--(Newsfile Corp. - May 25, 2021) -  MYM Nutraceuticals Inc. (CSE: MYM) (OTCQB: MYMMF) ("MYM" or the "Company") published a notice of meeting and record date for the upcoming special meeting of shareholders of MYM (the "Meeting") disclosing that the record date will be May 31, 2021 and the Meeting will be on July 5, 2021. At the Meeting, shareholders will be asked to consider and vote on a special resolution approving, among other things, the arrangement agreement entered...

    2021-05-25 8:30 AM EDT
  • MYM Releases Q3 2021 Financial Results

    Vancouver, British Columbia--(Newsfile Corp. - April 30, 2021) - MYM Nutraceuticals Inc., (CSE: MYM) (OTCQB: MYMMF) ("MYM" or the "Company") today announced its financial results for the three-month period ending February 28, 2021 ("Q3 2021"). The Company's Financial Statements and Management Discussion & Analysis ("MD&A") are available on sedar.com. Key Highlights for Q3 2021Gross revenue of $4.4 million, an increase of 8% from the prior quarterPositive EBITDA of $212,628Expanded distribution to three new markets: Yukon, Nunavut, and OntarioSubsequent to...

    2021-04-30 8:30 AM EDT
  • MYM Continues to Secure Additional Support for Merger with IMCC

    Total voting support agreements for the Transaction now represent 44.4%, or 162.7 million, of the total votes outstanding including all senior management and board membersShareholders to benefit from a global platform of premium and super premium brands and distribution through Canada, Israel and EuropeThe Transaction has been approved by an MYM Special Committee of Independent Directors Vancouver, British Columbia--(Newsfile Corp. - April 19, 2021) - MYM Nutraceuticals Inc. (CSE: MYM) (OTCQB: MYMMF) ("MYM" or the "Company"), is pleased to announce...

    2021-04-19 8:30 AM EDT
  • IM Cannabis to Acquire MYM Nutraceuticals and Its Licensed Producer Subsidiary, Highland Grow

    Highland Grow is currently profitable on an EBITDA basis and the Transaction is expected to be immediately accretive to IMCHighland Grow is expected to generate net revenue of $29 million and $38 million and gross margins of 34% to 36% in 2021 and 2022, respectively[1]Purchase price implies 2.3x net revenue and 6.7x EBITDA in 2022 with synergiesMYM shareholders will receive 0.022 IMC shares for each MYM share, representing a price of $0.195 based on respective closing prices on March 31,...

    2021-04-01 11:51 AM EDT
  • MYM Nutraceuticals Inc.: Highland Grow Expands Distribution into Nunavut

    Vancouver, British Columbia--(Newsfile Corp. - March 5, 2021) - MYM Nutraceuticals Inc., (CSE: MYM) (OTCQB: MYMMF) ("MYM" or the "Company") is pleased to announce its wholly owned subsidiary and Health Canada licensed cannabis producer, Highland Grow Inc., ("Highland Grow"), has received authorization from the Government of Nunavut to supply Highland Grow cannabis products throughout Nunavut."We are thrilled at the opportunity to work with the Government of Nunavut and share Highland Grow and Coastal Connection branded cannabis products for the benefit...

    2021-03-05 8:30 AM EST
  • MYM Nutraceuticals Inc: Highland Grow Expands Distribution into Ontario Increases Loan Facility to Support Growth

    Vancouver, British Columbia--(Newsfile Corp. - February 4, 2021) - MYM Nutraceuticals Inc., (CSE: MYM) (OTCQB: MYMMF) ("MYM" or the "Company") is pleased to announce its wholly owned subsidiary and Health Canada licensed cannabis producer, Highland Grow Inc., ("Highland Grow"), has entered into a supply agreement with the Ontario Cannabis Store ("OCS") to supply Highland Grow branded cannabis products throughout the province of Ontario.Under the terms of the agreement, Highland Grow will initially offer two cultivars, "White Lightning" and "Gaelic Fire",...

    2021-02-04 8:30 AM EST